Tower Research Capital (TRC)’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-9,805
| Closed | -$2.84K | – | 6147 |
|
|
2024
Q2 | $2.84K | Buy |
9,805
+8,271
| +539% | +$2.4K | ﹤0.01% | 4961 |
|
|
2024
Q1 | $22.1K | Buy |
1,534
+1,487
| +3,164% | +$21.4K | ﹤0.01% | 2912 |
|
|
2023
Q4 | $545 | Sell |
47
-446
| -90% | -$5.17K | ﹤0.01% | 5543 |
|
|
2023
Q3 | $7.4K | Buy |
493
+78
| +19% | +$1.17K | ﹤0.01% | 4471 |
|
|
2023
Q2 | $8.62K | Buy |
415
+2
| +0.5% | +$42 | ﹤0.01% | 4379 |
|
|
2023
Q1 | $4K | Sell |
413
-496
| -55% | -$4.8K | ﹤0.01% | 5132 |
|
|
2022
Q4 | $10K | Buy |
909
+253
| +39% | +$2.78K | ﹤0.01% | 4107 |
|
|
2022
Q3 | $9K | Buy |
656
+357
| +119% | +$4.9K | ﹤0.01% | 4720 |
|
|
2022
Q2 | $11K | Buy |
299
+277
| +1,259% | +$10.2K | ﹤0.01% | 4400 |
|
|
2022
Q1 | $2K | Sell |
22
-7
| -24% | -$636 | ﹤0.01% | 5636 |
|
|
2021
Q4 | $7K | Sell |
29
-245
| -89% | -$59.1K | ﹤0.01% | 4961 |
|
|
2021
Q3 | $97K | Buy |
+274
| New | +$97K | ﹤0.01% | 2429 |
|